Resmed Cdi stock

RMD · ASX · AUD

Compare Resmed Cdi
$35.44Change from previous close: −2.66%Absolute change: −$0.97

Close · November 20, 2026

Price history

−6.14% over the period

1 year: from $37.76 (November 20, 2025) to $35.44 (November 20, 2026), −6.14%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 20, 2026$35.44
October 30, 2026$35.51
September 30, 2026$31.98
August 31, 2026$33.04
July 31, 2026$29.79
June 30, 2026$28.88
May 29, 2026$28.75
April 30, 2026$29.78
March 31, 2026$32.16
February 27, 2026$36.07
January 30, 2026$37.54
December 31, 2025$35.94
November 28, 2025$39.31
November 20, 2025$37.76

At a glance

  • The company

    Digital health and cloud-connected medical devices for sleep, breathing health, and residential care software

  • Latest results

    Quarter to September 30, 2026 · EPS $2.92 (estimate $0.27)

TickerLandia's take on Resmed Cdi

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low$25.50
52-wk high$39.94

−11.27% from the 52-week high

Analysts · 13 analysts

Average target$43.19+21.87% vs. price

Buy 11 · Hold 2 · Sell 0 · Buy

TickerLandia Fingerprint: Resmed Cdi

Compared with similar companies: very high profitability.

Financials and price compared with 34 companies in the medical instruments & supplies industry, worldwide. Momentum and risk compared with 1,074 Asia-Pacific stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Resmed Cdi is cheaper than similar companies

Resmed Cdi's P/E (trailing 12 months): 22.3, −53% against the median of a group of 11 similar companies (47.0).

Compared with 11 similar companies

Resmed Cdi's metrics compared with similar companies
MetricResmed CdiPosition in the groupBand
P/E (trailing 12 months)22.3Low
Forward P/E18.8Middle
Operating margin34.0%High
ROE26.4%High
Debt/equity0.10Middle

Grey band: the middle half of the group; tick: the median; dot: Resmed Cdi. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

$1.41B

Latest quarter · Q3 2026

Net income

$418.41M

Latest quarter · Q3 2026

Quarterly net margin

29.6%

Latest quarter · Q3 2026

Numbers and valuation

Full valuation
Market cap
$49.85B
P/E
22.3
EPS
$1.59
Volume
1.13M
Daily trading
€44.05M
Dividend yield
0.71%
Last ex-dividend on November 11, 2026

How Resmed Cdi is changing

All results
  • Revenue grew 12.1% a year on average over the last 5 years

  • Operating margin rose from 27.3% to 34.0%

  • Profits turn into cash: free cash flow equal to 116% of net income

Returns

Resmed Cdi returns with dividends

$1,000 invested in Resmed Cdi 5 years ago, on November 22, 2021, would be worth $1,022 today with dividends reinvested: +2.22% in total, +0.44% per year. On price alone it would be $979 (−2.10%).

PeriodResmed CdiS&P/ASX 200$1,000 becomes
1 month+3.63%−2.54%$1,036
6 months+21.12%+1.13%$1,211
Year to date−1.39%−1.40%$986
1 year−5.41%+0.47%$946
3 years+58.31%+21.74%$1,583
5 years+2.22%+16.86%$1,022
10 years+382.92%+60.57%$4,829

Over the last 6 months it has done better than 50% of the stocks in the Healthcare sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. S&P/ASX 200: price only. Calculate your investment

The chart in detail

Resmed Cdi: technical analysis

Resmed Cdi shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 21.5% below its all-time closing high ($45.14, August 21, 2025).

Trend
No clear trend
RSI (14 sessions)
58
Between 30 and 70
vs 200-session average
+12.28%

Support and resistance

Price areas where Resmed Cdi has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance$38.98+10.00%3 touches, last on February 10, 2026
  2. Resistance$37.42+5.58%3 touches, last on October 30, 2026
  3. Resistance$35.46+0.06%2 touches, last on February 25, 2026
  4. Last price$35.44
  5. Support$33.33−5.96%3 touches, last on August 31, 2026
  6. Support$32.51−8.25%2 touches, last on November 3, 2026
  7. Support$31.68−10.62%2 touches, last on July 7, 2026

Volatility and risk

Over the last year it has moved less than the S&P/ASX 200.

Beta (1 year) vs S&P/ASX 200
0.45
Volatility (60 sessions, annualised)
24.2%
Largest fall in the last year
−34.27%

Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Resmed Cdi: seasonality

Average monthly price change over 27 years

+2.5%Jan+1.8%Feb+0.6%Mar+1.3%Apr−0.3%May+2.1%Jun+3.2%Jul+3.8%Aug−0.8%Sep+0.7%Oct+3.7%Nov+0.1%Dec

Over the last 27 years, the strongest month for Resmed Cdi has been August: +3.85% on average, positive in 16 years out of 27. The weakest has been September: −0.77% on average, positive in 11 years out of 27. November, the current month, has been positive in 18 years out of 26 (+3.68% on average).

Show chart data
MonthAverageMedianPositive years
January+2.48%+4.08%18 of 27
February+1.80%−1.36%13 of 27
March+0.59%+0.19%14 of 27
April+1.26%+1.55%19 of 27
May−0.32%+2.03%16 of 27
June+2.13%+2.22%18 of 27
July+3.20%+2.68%19 of 27
August+3.85%+4.03%16 of 27
September−0.77%−0.53%11 of 27
October+0.67%+0.52%14 of 27
November+3.68%+3.10%18 of 26
December+0.15%−0.93%11 of 27

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Resmed Cdi and its competitors

Employing 11,370 people, ResMed works in digital health and cloud-connected medical devices in the United States and abroad. Its devices cover sleep apnea diagnosis, with the ApneaLink Air portable tester, the NightOwl disposable device and the EasyCare Tx sleep lab solution, while therapy support comes through the AirView remote monitoring system and the myAir patient application. A separate software business serves home medical equipment and pharmacy providers through Brightree, home health and hospice agencies through HEALTHCAREfirst, and skilled nursing and senior living providers through MatrixCare and MEDIFOX DAN.

Headquarters
San Diego, United States
Employees
11,370
Resmed Cdi and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
Resmed CdiRMD$33.23B34.0%22.3+21.12%
HOYA7741$47.84B34.4%27.3−13.64%
Fisher And Paykel Healthcare CorpoFPH$15.85B27.6%57.7+47.73%
Lenskart SolutionsLENSKART$13.82B10.5%163.9+51.79%
AnsellANN$4.31B15.0%21.6+79.76%
ResMedRMD$33.14B34.0%21.5+12.28%

Same industry or related industries, similar size. Compare Resmed Cdi with its competitors · Full profile